Virtu Financial LLC Makes New $1.03 Million Investment in Tilray Inc (NASDAQ:TLRY)

Virtu Financial LLC acquired a new position in shares of Tilray Inc (NASDAQ:TLRY) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 773,923 shares of the company’s stock, valued at approximately $1,029,000.

A number of other institutional investors have also recently bought and sold shares of TLRY. Verdence Capital Advisors LLC acquired a new stake in shares of Tilray during the 4th quarter valued at about $29,000. Ameritas Advisory Services LLC acquired a new stake in shares of Tilray during the 4th quarter valued at about $32,000. Newman Dignan & Sheerar Inc. lifted its holdings in shares of Tilray by 61.9% during the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after buying an additional 10,000 shares during the last quarter. Brooklyn FI LLC acquired a new stake in shares of Tilray during the 4th quarter valued at about $36,000. Finally, Jones Financial Companies Lllp lifted its holdings in shares of Tilray by 125.7% during the 4th quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company’s stock valued at $42,000 after buying an additional 17,670 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Stock Up 0.2 %

Shares of TLRY stock opened at $0.65 on Monday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The stock’s 50 day simple moving average is $0.91 and its 200 day simple moving average is $1.30. The company has a market capitalization of $609.48 million, a price-to-earnings ratio of -2.17 and a beta of 2.13. Tilray Inc has a twelve month low of $0.58 and a twelve month high of $2.97.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, research analysts predict that Tilray Inc will post -0.2 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group lifted their price target on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $2.70.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.